Laurent Humeau - Net Worth and Insider Trading

Laurent Humeau Net Worth

The estimated net worth of Laurent Humeau is at least $60,418 dollars as of 2024-04-27. Laurent Humeau is the Chief Scientific Officer of Inovio Pharmaceuticals Inc and owns about 5,716 shares of Inovio Pharmaceuticals Inc (INO) stock worth over $60,418. Details can be seen in Laurent Humeau's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Laurent Humeau has not made any transactions after 2021-08-09 and currently still holds the listed stock(s).

Transaction Summary of Laurent Humeau

To

Laurent Humeau Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Laurent Humeau owns 1 companies in total, including Inovio Pharmaceuticals Inc (INO) .

Click here to see the complete history of Laurent Humeau’s form 4 insider trades.

Insider Ownership Summary of Laurent Humeau

Ticker Comapny Transaction Date Type of Owner
INO Inovio Pharmaceuticals Inc 2021-08-09 Chief Scientific Officer

Laurent Humeau Latest Holdings Summary

Laurent Humeau currently owns a total of 1 stock. Laurent Humeau owns 5,716 shares of Inovio Pharmaceuticals Inc (INO) as of August 9, 2021, with a value of $60,418.

Latest Holdings of Laurent Humeau

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INO Inovio Pharmaceuticals Inc 2021-08-09 5,716 10.57 60,418

Holding Weightings of Laurent Humeau


Laurent Humeau Form 4 Trading Tracker

According to the SEC Form 4 filings, Laurent Humeau has made a total of 7 transactions in Inovio Pharmaceuticals Inc (INO) over the past 5 years, including 2 buys and 5 sells. The most-recent trade in Inovio Pharmaceuticals Inc is the sale of 860 shares on August 9, 2021, which brought Laurent Humeau around $94,401.

Insider Trading History of Laurent Humeau

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Laurent Humeau Trading Performance

GuruFocus tracks the stock performance after each of Laurent Humeau's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Laurent Humeau is 3.7%. GuruFocus also compares Laurent Humeau's trading performance to market benchmark return within the same time period. The performance of stocks bought by Laurent Humeau within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Laurent Humeau's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Laurent Humeau

Average Return

429.75%

Average return per transaction

Outperforming Transactions

100%

2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.17 3.7 48.23 429.75 91.43 -3.66
Relative Return to S&P 500(%) 7.41 -2.62 42.6 413.32 68.08 -15.73

Laurent Humeau Ownership Network

Ownership Network List of Laurent Humeau

No Data

Ownership Network Relation of Laurent Humeau


Laurent Humeau Owned Company Details

What does Inovio Pharmaceuticals Inc do?

Who are the key executives at Inovio Pharmaceuticals Inc?

Laurent Humeau is the Chief Scientific Officer of Inovio Pharmaceuticals Inc. Other key executives at Inovio Pharmaceuticals Inc include Chief Medical Officer Michael John Sumner , CFO Peter Kies , and Chief Operating Officer Jacqueline Elizabeth Shea .

Inovio Pharmaceuticals Inc (INO) Insider Trades Summary

Over the past 18 months, Laurent Humeau made no insider transaction in Inovio Pharmaceuticals Inc (INO). Other recent insider transactions involving Inovio Pharmaceuticals Inc (INO) include a net sale of 17,501 shares made by David B. Weiner , and a net sale of 5,700 shares made by Lota S. Zoth .

In summary, during the past 3 months, insiders sold 0 shares of Inovio Pharmaceuticals Inc (INO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,933 shares of Inovio Pharmaceuticals Inc (INO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,933 shares.

Inovio Pharmaceuticals Inc (INO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Inovio Pharmaceuticals Inc Insider Transactions

No Available Data

Laurent Humeau Mailing Address

Above is the net worth, insider trading, and ownership report for Laurent Humeau. You might contact Laurent Humeau via mailing address: C/o Inovio Pharmaceuticals, Inc., 660 W. Germantown Pike, Suite 110, Plymouth Meeting Pa 19462.

Discussions on Laurent Humeau

No discussions yet.